SOUTH SAN FRANCISCO, Calif. (AP) _ Global Blood Therapeutics Inc. (GBT) on Monday reported a loss of $27.2 million in its fourth quarter.
The South San Francisco, California-based company said it had a loss of 74 cents per share.
The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 64 cents per share.
For the year, the company reported a loss of $82.5 million, or $2.48 per share.
Global Blood shares have more than doubled since the beginning of the year. In the final minutes of trading on Monday, shares hit $37.70, more than doubling in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GBT at https://www.zacks.com/ap/GBT
Keywords: Global Blood Therapeutics, Earnings Report